Notitia Biotechnologies
PrivateCompany Overview
Notitia Biotechnologies is a biotechnology company that develops microbiome-targeted biotherapeutics and products focused on the ecological restoration of the gut ecosystem.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, D2C Brands, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Notitia Biotechnologies Comparables
Compare Notitia Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biom Pharmaceutical | 78% | |
| Rise Therapeutics | 76% | |
| Kibow Therapeutics | 76% | |
Notitia Biotechnologies Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Monthly visitors grew 195% MoM, reaching 701.
- May 2, 2025
Monthly visitors grew 400% MoM.
Notitia Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Notitia Biotechnologies's valuation, stock price, and market status.